Post-SARS-CoV-2 Vaccine Monitoring of Disease Flares in Autoinflammatory Diseases

J Clin Immunol. 2022 May;42(4):732-735. doi: 10.1007/s10875-022-01225-5. Epub 2022 Feb 15.

Authors

Sara Alehashemi¹, Evelien van Gelderen², Andre Rastegar², Adriana A de Jesus², Raphaela Goldbach-Mansky²

Affiliations

¹ Translational Autoinflammatory Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. [email protected].
² Translational Autoinflammatory Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Intramural

MeSH terms

COVID-19 Vaccines
COVID-19* / prevention & control
Hereditary Autoinflammatory Diseases* / diagnosis
Humans
SARS-CoV-2
Symptom Flare Up
Vaccination

Substances

COVID-19 Vaccines